Counsel Portfolio Services’s Pacira BioSciences PCRX Stock Holding History

Counsel Portfolio Services’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$2.04M	Sell	60,416 -17,944	-23%	-$882K	0.2%	142
2016 Q1	$4.15M	Buy	78,360 +24,336	+45%	+$1.42M	0.55%	59
2015 Q4	$4.15M	Buy	54,024 +11,588	+27%	+$656K	0.43%	74
2015 Q3	$1.74M	Buy	42,436 +2,395	+6%	+$147K	0.19%	136
2015 Q2	$2.83M	Buy	40,041 +4,979	+14%	+$392K	0.29%	112
2015 Q1	$3.12M	Buy	35,062 +610	+2%	+$61.9K	0.31%	111
2014 Q4	$3.06M	Buy	34,452 +4,950	+17%	+$468K	0.31%	99
2014 Q3	$2.86M	Hold	29,502	–	–	0.3%	109
2014 Q2	$2.71M	Sell	29,502 -216	-0.7%	-$16.4K	0.26%	116
2014 Q1	$2.08M	Buy	+29,718	New	+$2.02M	0.21%	134

Other funds holding PCRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Counsel Portfolio Services's PCRX Position: Q2 2016 in Review

Counsel Portfolio Services reduced its Pacira BioSciences (PCRX) stake by 23% in Q2 2016, selling an estimated $882K and leaving 60,416 shares worth $2.04M. The position accounts for 0.2% of the portfolio, ranked #142.

Counsel Portfolio Services first reported a position in PCRX in Q1 2014 and has held it in 10 quarters since. The position peaked at $4.15M in Q1 2016. 183 funds tracked by Wall St. Rank hold PCRX as of Q2 2016.

Counsel Portfolio Services held 60,416 shares of Pacira BioSciences worth $2.04M as of Q2 2016.
Counsel Portfolio Services sold 17,944 Pacira BioSciences shares in Q2 2016, an estimated $882K.
Pacira BioSciences made up 0.2% of Counsel Portfolio Services's portfolio in Q2 2016, its #142 holding.
Counsel Portfolio Services first reported a position in Pacira BioSciences in Q1 2014 and has held it in 10 quarters since.
Counsel Portfolio Services's Pacira BioSciences position peaked at $4.15M in Q1 2016.
183 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2016.

Based on Counsel Portfolio Services's 13F filing for Q2 2016, filed 12 Aug 2016.